Study of Effectiveness of Mexyn-A
Launched by EVANGELICAL SYNOD MEDICAL CENTRE · Nov 30, 2007
Trial Information
Current as of June 28, 2025
Completed
Keywords
ClinConnect Summary
The primary clinical endpoint was to establish MEXYN-A efficacy and safety in abolishing or reducing pruritus related to cutaneous diseases, insect bites and poison ivy, within few seconds of the application. The secondary endpoint was to measure the itch free period as a result of the new intervention.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients suffering from severe itching due to : Atopic Dermatitis, contact dermatitis, psoriasis, urticaria, xerosis, prickly heat, genital pruritus, chicken pox, aquagenic pruritus, lichen planus, poison ivey, insect bites.
- • Past experience with the use of at least one conventional medication for pruritus or conventional medication for the same disorder patients suffered.
- Exclusion Criteria:
- • Patients who have taken any anti-pruritic drug during the month prior to participation.
- • Patients who have taken drugs for any reason for 2 days prior to participating in the study.
About Evangelical Synod Medical Centre
The Evangelical Synod Medical Centre is a leading healthcare institution dedicated to advancing medical knowledge and improving patient care through rigorous clinical research. Committed to ethical practices and the highest standards of scientific integrity, the Centre conducts a diverse range of clinical trials aimed at evaluating innovative treatments and therapies. With a multidisciplinary team of experienced professionals, the Evangelical Synod Medical Centre fosters collaboration between researchers, healthcare providers, and patients, ensuring that research outcomes translate into enhanced healthcare solutions for communities. Their mission is to contribute to the global body of medical research while upholding the values of compassion, excellence, and faith-based care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Ihab Akhnoukh
Principal Investigator
Evangelical Synod Medical Centre
Ashraf Khella
Study Director
Harpur Memorial Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials